$34 million financing "windfall" for Zonare:
This article was originally published in Clinica
Zonare Medical Systems, a developer of portable ultrasound products, is to receive a further $34m in financing from one of its initial investors, Earlybird Venture Capital. This latest round of financing would boost the total amount of financing raised by Zonare, formerly known as Novasonics, to $92.9m. Zonare's zone sonography platform is designed to offer solutions for a wide variety of imaging needs in general imaging, obstetrics, gynaecology, cardiology, vascular and other emerging ultrasound applications. According to the Mountain View, California firm, the worldwide ultrasound market is expected to exceed $3.6bn in 2004.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.